Danielle Duffy

Author PubWeight™ 6.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.	J Lipid Res	2008	2.51
2	Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.	Arterioscler Thromb Vasc Biol	2005	1.35
3	Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.	Arterioscler Thromb Vasc Biol	2008	0.92
4	Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia.	Pharmacotherapy	2014	0.82
5	Novel treatments for familial hypercholesterolemia: pharmacogenetics at work.	Pharmacotherapy	2014	0.76
6	Targeting lipoprotein (a): an evolving therapeutic landscape.	Curr Atheroscler Rep	2015	0.76
7	Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profiles.	Mutat Res	2006	0.75